Surgery is currently the first-line treatment for Cushing disease; however, studies of dopamine agonists have demonstrated effective control of cortisol secretion in patients with Cushing disease.
Bromocriptine is unique in that it does not have a specific receptor that mediates its action on glucose and lipid metabolism. Rather, its effects are mediated via resetting of dopaminergic and ...
In a recent study by Paolo Barone and colleagues, a dopamine agonist, pramipexole, improved depressive symptoms after 12 weeks in European and South African patients undergoing antiparkinsonian ...
Dopamine’s effects in the brain are mediated by postsynaptic D1 and D2 receptors. Adenosine A1 and A2A receptors are uniquely positioned to counteract the excessive stimulation of dopamine receptors ...
Scientists had previously identified the functions of two distinct pathways and types of dopamine receptors in the forebrain: the D1 receptors, which activate neurons, and the D2 receptors ...
This is an important behavioral, pharmacological intervention study of the effects of the catecholamine reuptake inhibitor methylphenidate (MPH) on value-based decision-making using a combination of ...